Ritalin sharpens decisions in some brains, not others
Ritalin is known as a focus medication. But it also influences how we make decisions under pressure. And that effect runs in opposite directions depending on the person.
Our behavior is guided by two systems simultaneously. One learns what produces rewards and what doesn’t (the instrumental system). The other responds automatically to environmental cues, like reaching for food you weren’t planning to eat because it smells good (the Pavlovian system). Normally both systems work together. Sometimes they conflict.
Catecholamines and cognitive control
Methylphenidate (the active compound in Ritalin) blocks the reuptake of catecholamines: signaling molecules such as dopamine and noradrenaline. These play a role in the prefrontal cortex, the brain region responsible for cognitive control. The effect of methylphenidate on cognitive control follows an inverted U-curve: too little or too much activity in that system is both detrimental, and the optimal level differs between individuals.
In the study, published in eLife, one hundred healthy participants completed a task requiring them to act (or not) in response to reward or avoidance cues. Methylphenidate was given after learning had already occurred, to test whether the effect operates purely on action control rather than through the learning process itself.
Working memory as a predictor
The difference in effect was related to participants’ working memory capacity (a measure of the ability to temporarily hold and manipulate information). People with high working memory capacity benefited from methylphenidate: their cognitive control over automatic responses improved. In people with lower capacity, the drug had a smaller or different effect.
This fits the broader idea of a baseline-dependent effect: where you start determines how a drug works for you. That is relevant for longevity research, because cognitive control and working memory decline with age. Whether methylphenidate shows the same profile in older adults has not been studied. This trial looked only at healthy younger and middle-aged adults.